Toolkit: Drug Pricing Overview – 119th Congress

The CSRxP toolkit provides key facts and background on the prescription drug pricing landscape in the United States, including data on price hikes outpacing inflation, rising launch prices, Big Pharma’s egregious abuse of the patent system, and big drug companies’ staggering spending on direct-to-consumer (DTC) advertising that increases utilization of high-priced brand name drugs and more.